Search Results - "SEKINE, I"

Refine Results
  1. 1

    Emerging ethnic differences in lung cancer therapy by Sekine, I, Yamamoto, N, Nishio, K, Saijo, N

    Published in British journal of cancer (02-12-2008)
    “…Although global clinical trials for lung cancer can enable the development of new agents efficiently, whether the results of clinical trials performed in one…”
    Get full text
    Journal Article
  2. 2

    Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy by Khan, Khaleque Newaz, Kitajima, Michio, Hiraki, Koichi, Fujishita, Akira, Sekine, Ichiro, Ishimaru, Tadayuki, Masuzaki, Hideaki

    Published in Human reproduction (Oxford) (01-03-2010)
    “…BACKGROUND Information is limited regarding the multifunctional role of GnRH agonist (GnRHa) therapy in reproductive diseases. We investigated the pattern of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors by Kusaba, T, Nakayama, T, Yamazumi, K, Yakata, Y, Yoshizaki, A, Nagayasu, T, Sekine, I

    Published in Journal of clinical pathology (01-08-2005)
    “…Background: The signal transducer and activator of transcription 3 (STAT3) is a key signalling molecule implicated in the regulation of growth and malignant…”
    Get full text
    Journal Article
  5. 5

    Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions by Okamoto, S, Jiang, Y, Kawamura, K, Shingyoji, M, Tada, Y, Sekine, I, Takiguchi, Y, Tatsumi, K, Kobayashi, H, Shimada, H, Hiroshima, K, Tagawa, M

    Published in Cell death & disease (01-11-2014)
    “…Zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, produced anti-tumor effects through apoptosis induction or S-phase arrest depending on human…”
    Get full text
    Journal Article
  6. 6

    A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy by Segawa, Y., Aogi, K., Inoue, K., Sano, M., Sekine, I., Tokuda, Y., Isobe, H., Ogura, T., Tsuboi, M., Atagi, S.

    Published in Annals of oncology (01-11-2009)
    “…Background: The 5-HT3 receptor antagonists (RAs) help maintain the standard of care, in various combinations with other agents, for prevention of…”
    Get full text
    Journal Article
  7. 7

    Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells by Takei, Y, Okamoto, S, Kawamura, K, Jiang, Y, Morinaga, T, Shingyoji, M, Sekine, I, Kubo, S, Tada, Y, Tatsumi, K, Shimada, H, Hiroshima, K, Yamaguchi, N, Tagawa, M

    Published in Cancer gene therapy (01-09-2015)
    “…We examined cytotoxicity of replication-competent type 5 adenoviruses (Ad5) in human pancreatic carcinoma cells with a p53 -defective genotype. The…”
    Get full text
    Journal Article
  8. 8

    Circulating endothelial cells in Kawasaki disease by NAKATANI, K., TAKESHITA, S., TSUJIMOTO, H., KAWAMURA, Y., TOKUTOMI, T., SEKINE, I.

    Published in Clinical and experimental immunology (01-03-2003)
    “…summary Recent reports have demonstrated that circulating endothelial cells (CECs) are observed in several diseases with vascular injury. Because Kawasaki…”
    Get full text
    Journal Article
  9. 9

    Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70 by Khan, Khaleque Newaz, Kitajima, Michio, Imamura, Takehito, Hiraki, Koichi, Fujishita, Akira, Sekine, Ichiro, Ishimaru, Tadayuki, Masuzaki, Hideaki

    Published in Human reproduction (Oxford) (01-10-2008)
    “…BACKGROUND We investigated the role of human heat-shock protein 70 (Hsp70) in Toll-like receptor 4 (TLR4)-mediated growth of endometriosis. METHODS TLR4…”
    Get full text
    Journal Article
  10. 10

    A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy by Maemondo, M., Masuda, N., Sekine, I., Kubota, K., Segawa, Y., Shibuya, M., Imamura, F., Katakami, N., Hida, T., Takeo, S.

    Published in Annals of oncology (01-11-2009)
    “…Background: This is a randomized, double-blind, dose-ranging study in patients receiving highly emetogenic chemotherapy (HEC) to evaluate the safety, efficacy,…”
    Get full text
    Journal Article
  11. 11

    Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic by Sakaida, Emiko, Sekine, Ikuo, Iwasawa, Shunichiro, Kurimoto, Ryota, Uehara, Takashi, Ooka, Yoshihiko, Akanuma, Naoki, Tada, Yuji, Imai, Chiaki, Oku, Tomoko, Takiguchi, Yuichi

    Published in Japanese journal of clinical oncology (01-02-2014)
    “…Extravasation, the accidental leakage of an anticancer agent from a vessel into the surrounding tissues, can lead to irreversible local injuries and severe…”
    Get full text
    Journal Article
  12. 12

    Corrosion inhibition of mild steel by schiff base compounds in various aqueous solutions: part 1 by Shokry, H, Yuasa, M, Sekine, I, Issa, R.M, El-baradie, H.Y, Gomma, G.K

    Published in Corrosion science (01-12-1998)
    “…The corrosion inhibition by Schiff base compounds derived from diamines and o-hydroxy, o-methoxy aromatic aldehydes was investigated by weight loss,…”
    Get full text
    Journal Article
  13. 13

    TTMPP-Catalyzed Addition of Alkynes Using Trimethylsilylacetylenes by Matsukawa, S., Sekine, I.

    Published in Synthetic communications (22-04-2009)
    “…A highly basic phosphine, tris(2,4,6-trimethoxyphenyl)phosphine (TTMPP), catalyzes alkynylation using trimethylsilylalkyne to give the corresponding products…”
    Get full text
    Journal Article
  14. 14

    Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials by Tanai, C, Nokihara, H, Yamamoto, S, Kunitoh, H, Yamamoto, N, Sekine, I, Ohe, Y, Tamura, T

    Published in British journal of cancer (07-04-2009)
    “…There are inadequate data on the outcomes of patients who declined to participate in randomised clinical trials as compared with those of participants. We…”
    Get full text
    Journal Article
  15. 15

    Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas by Alipov, G, Nakayama, T, Ito, M, Kawai, K, Naito, S, Nakashima, M, Niino, D, Sekine, I

    Published in Histopathology (01-02-2005)
    “…Aims : The high incidence of clinically diagnosed prostatic cancer is exceeded by the frequency of tumours detected at autopsy. The Ets‐1 proto‐oncogene is…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori by HAMANAKA, Y, NAKASHIMA, M, WADA, A, ITO, M, KURAZONO, H, HOJO, H, NAKAHARA, Y, KOHNO, S, HIRAYAMA, T, SEKINE, I

    Published in Gut (01-10-2001)
    “…Human beta-defensin 2 (hBD-2) plays a role in the innate defence system at mucosal surfaces. Colonisation of Helicobacter pylori in the stomach is an important…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20